0460.HKライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (29 4月 2024 @ 17:08):

Stats
本日の出来高	16.35M
平均出来高	7.60M
時価総額	5.20B
EPS	HKD0 ( 2024-03-27 )
Last Dividend	HKD0.0370 ( 2023-06-06 )
Next Dividend	HKD0 ( N/A )
P/E	-56.00
ATR14	HKD0.00100 (0.18%)

ボリューム相関

長: 0.02 (neutral)

短: 0.00 (neutral)

Signal:(36.365) Neutral

Sihuan Pharmaceutical 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Sihuan Pharmaceutical 相関 - 通貨/商品

0.57
( weak )

0.67
( moderate )

0.00
( neutral )

-0.55
( weak negative )

Sihuan Pharmaceutical 財務諸表

Annual	2023
収益:	HKD1.86B
総利益:	HKD1.30B (69.64 %)
EPS:	HKD-0.00580

FY	2023
収益:	HKD1.86B
総利益:	HKD1.30B (69.64 %)
EPS:	HKD-0.00580

FY	2022
収益:	HKD2.18B
総利益:	HKD1.49B (68.20 %)
EPS:	HKD-0.210

FY	2021
収益:	HKD3.29B
総利益:	HKD2.45B (74.39 %)
EPS:	HKD0.0440

Financial Reports:

No articles found.

Sihuan Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.0360 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.0370 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Sihuan Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.27 - low (8.85%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.0390	2011-09-21
Last Dividend	HKD0.0370	2023-06-06
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	23	--
Total Paid Out	HKD0.764	--
Avg. Dividend % Per Year	0.00%	--
Score	1.03	--
Div. Sustainability Score	3.27
Div.Growth Potential Score	0
Div. Directional Score	0.991	--

Next Divdend (Est)
(2024-10-25)

HKD0.0364 Estimate 3.62 %

Dividend Stability

0.29 Very Poor

Dividend Score

1.03

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6677.HK	Ex Dividend Junior	2023-06-01	Annually	0.00%
1899.HK	Ex Dividend Junior	2023-06-13	Annually	0.00%
0927.HK	Ex Dividend Knight	2023-08-29	Semi-Annually	0.00%
0057.HK	Ex Dividend Knight	2023-09-01	Semi-Annually	0.00%
2883.HK	Ex Dividend Knight	2023-06-07	Annually	0.00%
1480.HK	Ex Dividend Knight	2023-06-08	Sporadic	0.00%
0551.HK	Ex Dividend Junior	2023-09-12	Annually	0.00%
8053.HK	No Dividend Player	2023-09-28	Annually	0.00%
2001.HK	Ex Dividend Knight	2023-09-01	Annually	0.00%
1072.HK	Ex Dividend Junior	2023-06-30	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0290	1.500	-0.581	-0.871	[0 - 0.5]
returnOnAssetsTTM	-0.00468	1.200	-0.156	-0.187	[0 - 0.3]
returnOnEquityTTM	-0.0122	1.500	-1.247	-1.870	[0.1 - 1]
payoutRatioTTM	-5.53	-1.000	-10.00	10.00	[0 - 1]
currentRatioTTM	1.511	0.800	7.45	5.96	[1 - 3]
quickRatioTTM	1.160	0.800	7.88	6.30	[0.8 - 2.5]
cashRatioTTM	0.920	1.500	6.00	9.00	[0.2 - 2]
debtRatioTTM	0.106	-1.500	8.23	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.00318	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	-0.00510	2.00	-0.00255	-0.00510	[0 - 20]
debtEquityRatioTTM	0.277	-1.500	8.89	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.696	1.000	1.727	1.727	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0736	1.000	-3.47	-3.47	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0231	1.000	-0.983	-0.983	[0.2 - 2]
assetTurnoverTTM	0.161	0.800	-2.26	-1.806	[0.5 - 2]
Total Score				3.27

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-85.44	1.000	-8.73	0	[1 - 100]
returnOnEquityTTM	-0.0122	2.50	-0.802	-1.870	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.00510	2.00	-0.00170	-0.00510	[0 - 30]
dividendYielPercentageTTM	7.14	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.00318	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	-5.53	1.500	-10.00	10.00	[0 - 1]
pegRatioTTM	-0.934	1.500	-9.56	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0152	1.000	-2.12	0	[0.1 - 0.5]
Total Score				-1.286

Sihuan Pharmaceutical

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.